Trending News
News
News
ReproCELL Acquires Biopta
Acquisition to expand its drug discovery services.
News
Ready for the Change? – PTI Provides Guidance on New EU Clinical Trial Regulation
PTI prepares clinical trial and regulatory professionals for smooth transition to the new regulation with a live and accessible webinar e-course.
News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
News
Charles River Laboratories Acquires Oncotest GmbH
Expands oncology capabilities of Charles River discovery services.
News
ERS Genomics Licenses Genome-Editing Patents to Regeneron Pharmaceuticals
ERS Genomics has announced a patent license agreement whereby Regeneron Pharmaceuticals gains access to ERS’ CRISPR-Cas9 genome-editing patents for use in drug discovery and development.
News
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
News
Allergan, Rugen Therapeutics Announce Collaboration
Allergan and Rugen have identified and will advance novel, first-in-class small molecules to treat major unmet needs in neurology and psychiatry.
News
Catalent Biologics Expands Capabilities
Company announces multi-site expansion of its analytical and process development capabilities.
News
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Advertisement